EG17609A - Process for preparation of therapeutic agents from derivatives of propoimic acid. - Google Patents

Process for preparation of therapeutic agents from derivatives of propoimic acid.

Info

Publication number
EG17609A
EG17609A EG62286A EG62286A EG17609A EG 17609 A EG17609 A EG 17609A EG 62286 A EG62286 A EG 62286A EG 62286 A EG62286 A EG 62286A EG 17609 A EG17609 A EG 17609A
Authority
EG
Egypt
Prior art keywords
acid
propoimic
derivatives
preparation
therapeutic agents
Prior art date
Application number
EG62286A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Application granted granted Critical
Publication of EG17609A publication Critical patent/EG17609A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
EG62286A 1985-10-03 1986-10-02 Process for preparation of therapeutic agents from derivatives of propoimic acid. EG17609A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858524421A GB8524421D0 (en) 1985-10-03 1985-10-03 Therapeutic agents

Publications (1)

Publication Number Publication Date
EG17609A true EG17609A (en) 1995-04-30

Family

ID=10586136

Family Applications (1)

Application Number Title Priority Date Filing Date
EG62286A EG17609A (en) 1985-10-03 1986-10-02 Process for preparation of therapeutic agents from derivatives of propoimic acid.

Country Status (22)

Country Link
US (1) US4786495A (xx)
EP (1) EP0223369B1 (xx)
JP (1) JPS62111922A (xx)
KR (1) KR940000231B1 (xx)
AT (1) ATE59291T1 (xx)
AU (1) AU594264B2 (xx)
CA (1) CA1275930C (xx)
CS (1) CS271463B2 (xx)
DE (1) DE3676645D1 (xx)
DK (1) DK165165C (xx)
EG (1) EG17609A (xx)
ES (1) ES2033682T3 (xx)
FI (1) FI84314C (xx)
GB (1) GB8524421D0 (xx)
GR (1) GR3001312T3 (xx)
IE (1) IE59134B1 (xx)
IN (1) IN164030B (xx)
NO (1) NO173046C (xx)
NZ (1) NZ217703A (xx)
PT (1) PT83474B (xx)
RU (1) RU1800996C (xx)
ZA (1) ZA867309B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
GB8701392D0 (en) * 1987-01-22 1987-02-25 Boots Co Plc Therapeutic agents
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
US5286751A (en) * 1987-12-24 1994-02-15 Analgesic Associates Sustained/enhanced antipyretic response
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
US5189066A (en) * 1989-11-22 1993-02-23 The Procter & Gamble Company Pharmaceutical compositions of tebufelone
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5545628A (en) 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
DK0996429T3 (da) * 1997-10-27 2003-05-26 Merck Patent Gmbh Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
DE60318446T2 (de) 2002-07-15 2008-05-21 Alcon Inc. Nichtpolymere lipophile pharmazeutische implantat-zusammensetzungen für die intraokulare anwendung
ATE424187T1 (de) * 2002-07-15 2009-03-15 Alcon Inc Bioerodierbare folie zur abgabe eines ophthalmischen arzneimittels
WO2004006957A1 (en) * 2002-07-15 2004-01-22 Alcon, Inc. Pharmaceutical compositions for otic use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
US3966978A (en) * 1975-04-25 1976-06-29 American Cyanamid Company 4-Biphenylacetic acid as an inhibitor of platelet aggregation
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
JPS5913720A (ja) * 1982-07-15 1984-01-24 Green Cross Corp:The フルルビプロフエン脂肪乳剤
IT1170238B (it) * 1982-12-06 1987-06-03 Upjohn Co Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
US4473584A (en) * 1982-12-06 1984-09-25 The Upjohn Company Treatment of Type I Herpes virus with flurbiprofen
US4477468A (en) * 1982-12-06 1984-10-16 The Upjohn Company Treatment of type II herpes virus with flurbiprofen
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
JPS601122A (ja) * 1983-06-20 1985-01-07 Green Cross Corp:The ビフエニリルプロピオン酸誘導体脂肪乳剤
US4543251A (en) * 1983-12-09 1985-09-24 Toko Yakuhin Industry Co., Ltd. Gel preparations for external application
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
EP0275526A3 (en) * 1986-12-27 1990-01-31 Banyu Pharmaceutical Co., Ltd. Composition for administration through a body cavity

Also Published As

Publication number Publication date
EP0223369B1 (en) 1990-12-27
GR3001312T3 (en) 1992-08-31
DK165165B (da) 1992-10-19
FI863976A0 (fi) 1986-10-01
NO173046B (no) 1993-07-12
US4786495A (en) 1988-11-22
DK453386D0 (da) 1986-09-23
IE862449L (en) 1987-04-03
NO863935L (no) 1987-04-06
NZ217703A (en) 1989-01-06
AU594264B2 (en) 1990-03-01
RU1800996C (ru) 1993-03-07
DE3676645D1 (de) 1991-02-07
CS271463B2 (en) 1990-10-12
EP0223369A2 (en) 1987-05-27
IE59134B1 (en) 1994-01-12
FI84314C (fi) 1991-11-25
EP0223369A3 (en) 1987-12-02
PT83474B (pt) 1989-02-28
KR870003772A (ko) 1987-05-04
NO863935D0 (no) 1986-10-02
FI84314B (fi) 1991-08-15
DK453386A (da) 1987-04-04
ZA867309B (en) 1987-05-27
ES2033682T3 (es) 1993-04-01
DK165165C (da) 1993-03-01
KR940000231B1 (ko) 1994-01-12
NO173046C (no) 1993-10-20
AU6346586A (en) 1987-04-09
ATE59291T1 (de) 1991-01-15
JPS62111922A (ja) 1987-05-22
FI863976A (fi) 1987-04-04
CS708386A2 (en) 1990-02-12
JPH0428243B2 (xx) 1992-05-13
CA1275930C (en) 1990-11-06
GB8524421D0 (en) 1985-11-06
PT83474A (en) 1986-11-01
IN164030B (xx) 1988-12-31

Similar Documents

Publication Publication Date Title
EG17609A (en) Process for preparation of therapeutic agents from derivatives of propoimic acid.
MX9202215A (es) Composicion farmaceutica que comprende s(-) 2(4- iso butil fenil) propionato de sodio y proceso para su preparacion.
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
ES2032382T3 (es) Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis.
DE60000133D1 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
EP0201743A3 (en) Dipeptide derivatives of fatty acids, process for preparing them, pharmaceutical composition and use
YU89891A (sh) SMEŠE TGF-beta
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
EP0302481A3 (en) Use of free fatty acids for the manufacture of a medicament for treatment of diabetes mellitus
ATE179889T1 (de) Arzneimittel, die ester omega-3 polyungesättigter säuren enthalten und deren verwendung in der topischen behandlung morbider erkrankungen
ES8304058A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10,14-hexadecapentaenoico.
PT88634A (pt) A process for the preparation of catechol carboxylic acid derivatives and of pharmaceutical compositions containing the same
JPS56110679A (en) 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it
AU3929789A (en) New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as medicinal agents, pharmaceutical products and intermediates
HUT52388A (en) Process for producing pharmaceutical compositions comprising unsaturated fatty acids and selenium as active ingredient
JPS56128731A (en) Ester of arylpropionic acid, manufacture and medicine of effective ingredient
IT1270699B (it) Sali dell'acido s(+)-2-(4-isobutilfenil)propionico con mono-, di- e trialcanolammine
IT1227158B (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.
IT7822772A0 (it) Derivato furanico per impiego quale prodotto farmaceutico particolarmente per il trattamentodi malattie reumatiche e metodo per la sua preparazione.
IT1255236B (it) Composizione farmaceutica idrofila per uso topico